Refund Policy Before Prescription Approval: If you're not approved for treatment after assessment, you receive a full refund and the consultation is free
Skura supports you throughout your journey and ensures you achieve long-lasting results
A punch biopsy may be considered, prior to initiating topical treatments, for superficial BCC to assess tumour thickness and confirm diagnosis
Retatrutide adds glucagon receptor agonism, which may contribute to increased energy expenditure, enhanced hepatic lipolysis, and liver fat reduction mechanisms absent from Tirzepatides profile
Even using this strategy some patients (minority) do have issues with sleep for the first 1-2 days after each injection
Retatrutide is an investigational peptide compound studied for its interaction with three major metabolic receptor pathways: GLP-1 Glucagon-Like Peptide-1 receptor GIP Glucose-Dependent Insulinotropic Polypeptide receptor Glucagon receptor The combination of these three pathways makes Retatrutide an important subject of research into metabolic signalling, energy balance, glucose regulation and body-weight regulation